Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
公开号:US10632135B2
公开(公告)日:2020-04-28
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease.
可口服的化合物、制备相同化合物的工艺及其作为治疗大肠杆菌诱发的炎症性肠病(如羊角风病)的抗粘连药物的用途。